173 results on '"Blagova O"'
Search Results
2. Rendu-Osler-Weber Disease with High Pulmonary Hypertension and Interstitial Lung Disease
3. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
4. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
5. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
6. Prevalence of myocarditis, genetic cardiomyopathies and their combinations among patients of the Cardiology Hospital of the V.N. Vinogradov Faculty Therapeutic Clinic of the Sechenov University
7. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
8. Thromboembolic mask of severe lymphocytic myopericarditis: possibilities of clinical and morphological diagnostics and complex treatment
9. Infective and nonbacterial thrombotic endocarditis in patients with post-COVID-19 viral-immune myocarditis
10. Noncompact Myocardium with Dilated Phenotype: Manifestations, Treatment and Outcomes in Comparison with Other Forms of Dilated Cardiomyopathy Syndrome
11. Post-COVID morphologically proved endocarditis: infective and nonbacterial forms
12. 2020 Clinical practice guidelines for Myocarditis in adults
13. Spectrum of desmosomal gene variations in patients with arrhythmogenic right ventricular cardiomyopathy
14. Director of the Faculty Therapeutic Clinic Nikolay Fedorovich Golubov: Scientific Activity, Last Years of Life and Finding of the Lost Grave (by the 165th Anniversary from Birthday)
15. Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias
16. Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course
17. Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
18. Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy
19. The correlation of anti-heart antibodies levels with clinical manifestations and outcomes in patients with COVID-19
20. Structural and molecular markers of aging heart: Sechenov University classification
21. Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2–9 months after acute COVID-19
22. Clinical and morphological characteristics of COVID-19-associated myocarditis
23. Controversial and open issues of diagnosis and treatment of myocarditis (based on the discussion of Russian national recommendations)
24. Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
25. Evolution of diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy and their application in clinical practice
26. Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms
27. Contribution of concomitant myocarditis to the development of various clinical types of arrhythmogenic right ventricular cardiomyopathy
28. Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy)
29. Myocardial morphological changes and pulmonary vein catheter ablation efficacy in patients with atrial fibrillation
30. Verified chronic severe giant cell myocarditis: an inevitable choice for heart transplantation
31. Pericarditis in contemporary therapeutic clinic: nosological spectrum, approaches to diagnosis and treatment
32. Combination of chronic myocarditis and progressive coronary artery disease: differential diagnosis and stepwise treatment
33. Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine
34. Anticardiac antibodies in patients with severe and moderate COVID-19 (correlations with the clinical performance and prognosis)
35. Combination of Arrhythmogenic Right Ventricular Dysplasia with Left Ventricular Non-Compaction as a Special Form of Cardiomyopathy: Clinic, Diagnostics, Genetic, Natural Course
36. COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
37. Plasma exchange in patients with myocarditis: comparison study
38. COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1)
39. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical
40. Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman
41. Cardioverter-defibrillators in patients with dilated cardiomyopathy syndrome: predictors of appropriate shocks and influence on the outcomes
42. Massive tuberculous exudative pericarditis under the guise of hydropericardium in a patient with non-compaction cardiomyopathy: diagnosis and treatment
43. P4682Left ventricular noncompaction in adults: complications, their predictors and outcomes
44. P5564The myocarditis as a regular phenomenon in primary noncompact myocardium: clinical and morphological diagnostics, significance and treatment
45. P339The factors associated with death, transplantation and appropriate defibrillators shocks in patients with dilated cardiomyopathy depending on its etiology
46. Syndrome of Primary Myocardial Hypertrophy: Clinical and Morphological, Genetic Diagnostics and Comparison of Sarcomerial Variants of Cardiomyopathy and its Phenocopy
47. The role of inflammatory theory in the pathogenesis of atrial fibrillation
48. INDICATIONS FOR IMPLANTATION AND EFFICIENCY OF CARDIOVERTER-DEFIBRILLATORS IN PATIENTS WITH DILATED CARDIOMYOPATHY
49. Morphologically proved ANCA positive Loeffler’s pancarditis: medical and surgical treatment
50. Register of adult patients with noncompact left ventricular myocardium: classification of clinical forms and a prospective assessment of progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.